Early diagnosis and personalized therapy: Pirogov University presented promising developments to Anastasia Rakova

Anastasia Rakova, Deputy Mayor of Moscow for Social Development, together with the Medical Technology team visited Pirogov University. During the visit, the guests met with Sergey Lukyanov, Rector of Pirogov University, and scientists from the Institute of Translational Medicine to discuss key projects in the field of predictive medicine.

Pirogov University presented the results of research carried out with the support of Medtech within the framework of the grant program of the Mayor of Moscow. Scientists are working on projects in the field of molecular immunomedicine, collaborating with leading research and medical centers.

One of the key focuses of the Institute of Translational Medicine is predictive medicine in oncology. Among the most significant developments, there are several.

Predicting the effectiveness of immunotherapy.

Scientists are developing tests based on immune markers that determine with over 92% accuracy whether immunotherapy is suitable for a patient. This significantly increases the chances of successful treatment.

Analysis of circulating tumor DNA by NGS method.

The new highly sensitive and minimally invasive test allows you to track the remnants of the tumor after treatment, evaluate the effectiveness of therapy, detect recurrence in time and adjust the treatment regimen.

In the future, these technologies will be introduced into the practice of Moscow hospitals, which will make the diagnosis and treatment of oncological diseases more accurate and effective.

Back